Monica Elisabeta Maxim

Background/Objectives: Cinnamon bark essential oil (CEO) possesses antimicrobial, antioxidant, and anti-inflammatory properties. However, its topical application is limited by poor aqueous solubility, volatility, and chemical instability. The aim of this study was to develop gelled oil-in-water microemulsions stabilized with Decyl Glucoside for the cutaneous delivery of CEO and to evaluate their physicochemical and pharmaceutical characteristics. Methods: Pseudoternary phase diagrams were constructed to identify the microemulsion regions using Decyl Glucoside, propylene glycol, CEO, isopropyl myristate, and water. Selected CEO-loaded microemulsions were characterized in terms of droplet size, polydispersity index, zeta potential, refractive index, viscosity, and apparent pH, and were subsequently gelled with Aerosil^® 200. The resulting gelled microemulsions were evaluated for CEO content, apparent pH, rheological and textural properties, spreadability, in vitro release and skin permeation studies. The short-term stability of both liquid and gelled microemulsions was also assessed over 45 days. Results: Three CEO-loaded oil-in-water microemulsions were selected from the isotropic regions of the pseudoternary phase diagrams and successfully transformed into homogeneous gelled systems without phase separation. CEO incorporation increased the storage modulus and yield stress of the gelled formulations compared with the corresponding blank systems. The surfactant-to-cosurfactant ratio markedly influenced the rheological properties, mechanical strength, and in vitro release and skin permeation of CEO. Among the investigated formulations, MEG-CEO-2 provided the best balance between mechanical properties, CEO release, and skin permeation. Both liquid and gelled microemulsions maintained their principal physicochemical characteristics during the 45-day stability assessment. Conclusions: Decyl Glucoside-stabilized gelled microemulsions exhibited physicochemical and pharmaceutical properties supporting their further investigation as topical delivery systems for CEO. The results demonstrate that the surfactant-to-cosurfactant ratio can be used to tailor formulation performance, supporting a rational approach for the development of CEO-loaded dermal delivery systems. However, preservation of the biological activities of CEO following incorporation into these systems remains to be experimentally established.

In vitro tumor spheroids have proven to be useful 3D tumor culture models for drug testing, and determining the molecular mechanism of tumor progression and cellular interactions. Therefore, there is a continuous search for their industrial scalability and routine preparation. Considering that hydrogels are promising systems that can favor the formation of tumor spheroids, our study aimed to investigate and develop less expensive and easy-to-use amorphous and crosslinked hydrogels, based on natural compounds such as sodium alginate (NaAlg), aloe vera (AV) gel powder, and chitosan (CS) for tumor spheroid formation. The ability of the developed hydrogels to be a potential spheroid-forming system was evaluated using MDA-MB-231 and U87MG cancer cells. Spheroid abilities were influenced by pH, viscosity, and crosslinking of the hydrogel. Addition of either AV or chitosan to sodium alginate increased the viscosity at pH 5, resulting in amorphous hydrogels with a strong gel texture, as shown by rheologic analysis. Only the chitosan-based gel allowed formation of spheroids at pH 5. Among the variants of AV-based amorphous hydrogels tested, only hydrogels at pH 12 and with low viscosity promoted the formation of spheroids. The crosslinked NaAlg/AV, NaAlg/AV/glucose, and NaAlg/CS hydrogel variants favored more efficient spheroid formation. Additional studies would be needed to use AV in other physical forms and other formulations of hydrogels, as the current study is an initiation, in evaluating the potential use of AV gel in tumor spheroid formation systems.

Biocompatible gel microemulsions containing natural origin excipients are promising nanocarrier systems for the safe and effective topical application of hydrophobic drugs, including antifungals. Recently, to improve fluconazole skin permeation, tolerability and therapeutic efficacy, we developed topical biocompatible microemulsions based on cinnamon, oregano or clove essential oil (CIN, ORG or CLV) as the oil phase and sucrose laurate (D1216) or sucrose palmitate (D1616) as surfactants, excipients also possessing intrinsic antifungal activity. To follow up this research, this study aimed to improve the adhesiveness of respective fluconazole microemulsions using chitosan (a biopolymer with intrinsic antifungal activity) as gellator and to evaluate the formulation variables’ effect (composition and concentration of essential oil, sucrose ester structure) on the gel microemulsions’ (MEGELs) properties. All MEGELs were evaluated for drug content, pH, rheological behavior, viscosity, spreadability, in vitro drug release and skin permeation and antifungal activity. The results showed that formulation variables determined distinctive changes in the MEGELs’ properties, which were nevertheless in accordance with official requirements for semisolid preparations. The highest flux and release rate values and large diameters of the fungal growth inhibition zone were produced by formulations MEGEL-FZ-D1616-CIN 10%, MEGEL-FZ-D1216-CIN 10% and MEGEL-FZ-D1616-ORG 10%. In conclusion, these MEGELs were demonstrated to be effective platforms for fluconazole topical delivery.

The nanofiltration composite membranes were obtained by incorporation of KIT-6 ordered mesoporous silica, before and after its functionalization with amine groups, into polyphenylene-ether-ether-sulfone (PPEES) matrix. The incorporation of silica nanoparticles into PPEES polymer matrix was evidenced by FTIR and UV–VIS spectroscopy. SEM images of the membranes cross-section and their surface topology, evidenced by AFM, showed a low effect of KIT-6 silica nanoparticles loading and functionalization. The performances of the obtained membranes were appraised in permeation of Chaenomeles japonica fruit extracts and the selective separation of phenolic acids and flavonoids. The obtained results proved that the PPEES with functionalized KIT-6 nanofiltration membrane, we have prepared, is suitable for the polyphenolic compound’s concentration from the natural extracts.

To initiate our research into the development of biocompatiîle gelled-microemulsions based on essential oils (EOs) and sucrose esters (SEs) for the topical delivery of fluconazole, this formulation study investigated the usefulness of two relatively harmless natural non-ionic surfactants from the group of SEs (sucrose laurate and stearate) to form, in the presence of antifungal EOs, stable, isotropic microemulsions effective on fluconazole solubilization. Fluconazole’s solubility in EO significantly depended on their chemical composition, showing higher values for cinnamon, oregano and clove essential oils, further selected as oil phase components for microemulsion formulations. The phase behavior of several EO–isopropyl miristate/SE–isopropanol/water systems was assessed through pseudo-ternary phase diagrams constructed by microplate dilution technique. The hydrocarbon chain length of the SE and EO type strongly influenced the size of the microemulsion region in the pseudo-ternary phase diagrams. Ten microemulsion formulations containing 2% fluconazole, 6% or 10% oil mixture of EO–isopropyl myristate in 1:1 ratio, 45% SE-isopropanol mixture and water, were selected and evaluated for physicochemical properties (droplet size, polydispersity, viscosity, refractive index, zeta potential and pH). All formulations were physicochemically acceptable, but viscosity enhancement and further in vitro and in vivo tests are required for the development of biocompatible, clinically safe and effective fluconazole topical preparations.